A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Rapid Test for Fecal Calprotectin Levels in Children With Crohn Disease

(2012) KL Kolho et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin

(2011) Alberto Dolci et al.   CLINICA CHIMICA ACTA

The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease

(2011) James D. Lewis   GASTROENTEROLOGY

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study

(2011) Gianmichele Meucci et al.   INFLAMMATORY BOWEL DISEASES

Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease

(2011) Marco Daperno et al.   Journal of Crohns & Colitis

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

(2011) Michael J. Sydora et al.   Journal of Crohns & Colitis

Evaluation of the Quantum Blue(R) rapid test for faecal calprotectin

(2011) J. Wassell et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity

(2010) Miguel Regueiro et al.   INFLAMMATORY BOWEL DISEASES

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Clinical implications of mucosal healing for the management of IBD

(2009) Guillaume Pineton de Chambrun et al.   Nature Reviews Gastroenterology & Hepatology

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

(2009) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

(2008) T. SIPPONEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

(2008) Jennifer Jones et al.   Clinical Gastroenterology and Hepatology

Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

(2008) Jun-Ying Xiang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES